GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status.

Moretti, Isabele Fattori; Lerario, Antonio Marcondes; Sola, Paula Rodrigues; Macedo-da-Silva, Janaína; Baptista, Mauricio da Silva; Palmisano, Giuseppe; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi.

Afiliação

Moretti IF; Laboratory of Molecular and Cellular Biology (LIM 15), Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 01246-903, SP, Brazil.
Lerario AM; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI 48108, USA.
Sola PR; Laboratory of Molecular and Cellular Biology (LIM 15), Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 01246-903, SP, Brazil.
Macedo-da-Silva J; GlycoProteomics Laboratory, Department of Parasitology, ICB, University of Sao Paulo, São Paulo 05508-000, SP, Brazil.
Baptista MDS; Biochemistry Department, Institute of Chemistry, Universidade de Sao Paulo, São Paulo 05508-900, SP, Brazil.
Palmisano G; GlycoProteomics Laboratory, Department of Parasitology, ICB, University of Sao Paulo, São Paulo 05508-000, SP, Brazil.
Oba-Shinjo SM; Laboratory of Molecular and Cellular Biology (LIM 15), Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 01246-903, SP, Brazil.
Marie SKN; Laboratory of Molecular and Cellular Biology (LIM 15), Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 01246-903, SP, Brazil.

Cancers (Basel) ; 15(3)2023 Jan 18.

Article em En | MEDLINE | ID: mdl-36765551